# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and maintains $41 pric...
Barrington Research analyst Michael Petusky reiterates Dentsply Sirona (NASDAQ:XRAY) with a Outperform and maintains $41 pri...
Needham analyst David Saxon reiterates Dentsply Sirona (NASDAQ:XRAY) with a Buy and maintains $42 price target.